AG00352Q

23978-09-8 | 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane

Chemical structure of 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, CAS 23978-09-8
AG00352Q
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 23978-09-8
Catalog Number AG00352Q(AGN-PC-0JLAT2)
Chemical Name 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
EC Number 245-962-4
IUPAC Name 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
InChI InChI=1S/C18H36N2O6/c1-7-21-13-14-24-10-4-20-5-11-25-17-15-22-8-2-19(1)3-9-23-16-18-26-12-6-20/h1-18H2
InChI Key AUFVJZSDSXXFOI-UHFFFAOYSA-N
MDL Number MFCD00005111
Molecular Formula C18H36N2O6
Molecular Weight 376.4882
NSC Number 264495
SMILES N12CCOCCOCCN(CCOCCOCC1)CCOCCOCC2
UNII 18V22YHN6G
Synonyms
A-(222), cryptand 222, cryptating agent 222, Kryptofix 222, 23978-09-8, 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, Kryptofix 222, Cryptand 222, Cryptating agent 222, Cryptofix 222, Kriptofix 222, Cryptate 222, Ligand 222, Kryptand 222, Cryptand C 222, Crypt-2,2,2, UNII-18V22YHN6G, NSC 264495, Cryptand 2.2.2, Kryptofix Merck 222, C18H36N2O6, EINECS 245-962-4, BRN 0620282, 18V22YHN6G, 13,16,21,24-Hexaoxa-1,10-diazabicyclo-(8,8,8)-hexacosane, AUFVJZSDSXXFOI-UHFFFAOYSA-N, AK111408, 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo(8.8.8)hexacosane, Kryptofix(R) 222, 98%, 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]-hexacosane (Kryptofix 2.2.2), Kryptofix-222, 2,2-Cryptand, MFCD00005111, PubChem2356, 2,2,2-Cryptand, 2.2.2-Cryptand, Cryptand(2.2.2), 2,2,2-Crypt, ACMC-209g7j, AC1L2IP5, AC1Q70RH, SCHEMBL27017, CTK1A2041, KS-00000NVQ, DTXSID00178697, Cryptand 222 (Kryptofix 222), ZINC3882229, 1701AB, ANW-25277, BBL028994, NSC264495, STK530369, AKOS005463220, AKOS015854436, ACN-028018, CS-W011776, DS-5217, FC-4101, MCULE-2208629745, NSC-264495, RTR-011099, AJ-74266, BC600194, CC-17419, LS-75514, SC-48865, SY010940, TR-011099, FT-0617280, ST50306906, MFCD00005111 (95%), 978H098, C-34127, J-015297, I14-61495, 4,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8.]hexacosane, 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 98%, Fludeoxyglucose Related Compound A, United States Pharmacopeia (USP) Reference Standard, Cryptand-222, CID72801, C18-H36-N2-O6, N12CCOCCOCCN(CCOCCOCC1)CCOCCOCC2, H0932, 4,7,13,16,21,24-Hexa-oxa-1,10-diazabicyclo[8.8.8]hexacosane, 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane (Kryptofix(R) 222), 4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane, 98% - 1G 1g,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited